Beta-blockers at Noncardiac Surgery Up CV Risk in Lower-Risk Cohort

Patients taking them for uncomplicated hypertension who stay on them during surgery have worse 30-day outcomes, says a Danish national cohort study; the authors say their results are likely generalizable.